Profusa, Inc.

Profusa, Inc.

Unknown Berkeley, CA, United States NVACW (NCM)

Profusa, Inc. develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.

Stock Performance (90 Days)

Data through Oct 28, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Other Unknown Companies

View All →

Frequently Asked Questions

Has Profusa, Inc. had layoffs?
No layoff events have been recorded for Profusa, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
Is Profusa, Inc. a publicly traded company?
Yes, Profusa, Inc. is publicly traded under the ticker symbol NVACW on the NCM.
Where is Profusa, Inc. headquartered?
Profusa, Inc. is headquartered in Berkeley, CA, United States at 626 Bancroft Way, Berkeley, CA 94710, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.